Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate.

S1P (sphingosine 1-phosphate) represents one of the key latest additions to the list of vasoactive substances that modulate vascular tone. PAR-2 (proteinase activated receptor-2) has been shown to be involved in cardiovascular function. In the present study, we investigated the involvement of PAR-2 in S1P-induced effect on vascular tone. The present study has been performed by using isolated mouse aortas. Both S1P and PAR-2 agonists induced endothelium-dependent vasorelaxation. L-NAME (N(G)-nitro-L-arginine methyl ester) and wortmannin abrogated the S1P-induced vasorelaxatioin, while significantly inhibiting the PAR-2-mediated effect. Either ENMD1068, a PAR-2 antagonist, or gabexate, a serine protease inhibitor, significantly inhibited S1P-induced vasorelaxation. Aortic tissues harvested from mice overexpressing PAR-2 displayed a significant increase in vascular response to S1P as opposed to PAR-2-null mice. Immunoprecipitation and immunofluorescence studies demonstrated that S1P(1) interacted with PAR-2 and co-localized with PAR-2 on the vascular endothelial surface. Furthermore, S1P administration to vascular tissues triggered PAR-2 mobilization from the plasma membrane to the perinuclear area; S1P-induced translocation of PAR-2 was abrogated when aortic rings were pre-treated with ENMD1068 or when caveolae dysfunction occurred. Similarly, experiments performed in cultured endothelial cells (human umbilical vein endothelial cells) showed a co-localization of S1P(1) and PAR2, as well as the ability of S1P to induce PAR-2 trafficking. Our results suggest that S1P induces endothelium-dependent vasorelaxation mainly through S1P(1) and involves PAR-2 transactivation.

[1]  K. Vávrová,et al.  Complex modulation of peptidolytic activity of cathepsin D by sphingolipids. , 2011, Biochimica et biophysica acta.

[2]  R. Kaunas,et al.  Fluid Shear Stress and Sphingosine 1-Phosphate Activate Calpain to Promote Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Membrane Translocation and Endothelial Invasion into Three-dimensional Collagen Matrices* , 2011, The Journal of Biological Chemistry.

[3]  K. Inouye,et al.  Activation of matriptase zymogen. , 2011, Journal of biochemistry.

[4]  A. Moon,et al.  Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3–Gαq coupling , 2011, Journal of Cell Science.

[5]  S. Pitson.  Regulation of sphingosine kinase and sphingolipid signaling. , 2011, Trends in biochemical sciences.

[6]  B. Levkau,et al.  Endothelial Functions of Sphingosine-1-phosphate , 2010, Cellular Physiology and Biochemistry.

[7]  S. Coughlin,et al.  Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. , 2009, The Journal of clinical investigation.

[8]  Y. Hannun,et al.  Bioactive sphingolipids: metabolism and function This work was supported by National Institutes of Health Grants GM-43825 and CA-87584. Published, JLR Papers in Press, November 17, 2008. , 2009, Journal of Lipid Research.

[9]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling Supported by National Institutes of Health Grants R37GM043880, RO1CA61774, RO1AI050094, and U19AI077435-018690 (SS) and the NIMH Intramural Research Program (SM). Published, JLR Papers in Press, November 5, 2008. , 2009, Journal of Lipid Research.

[10]  T. Michel,et al.  S1P and eNOS regulation. , 2008, Biochimica et biophysica acta.

[11]  B. Levkau.  Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness. , 2008, Circulation research.

[12]  J. Chun,et al.  Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.

[13]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[14]  U. Pendurthi,et al.  Modulation of Tissue Factor–Factor VIIa Signaling by Lipid Rafts and Caveolae , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[15]  P. Elias,et al.  Serine protease signaling of epidermal permeability barrier homeostasis. , 2006, The Journal of investigative dermatology.

[16]  W. Ferrell,et al.  Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[17]  A. Fontana,et al.  Essential requirement for sphingosine kinase activity in eNOS‐dependent NO release and vasorelaxation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  R. Sorrentino,et al.  Sphingosine 1-Phosphate Induces Endothelial Nitric-Oxide Synthase Activation through Phosphorylation in Human Corpus Cavernosum , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  S. Fiorucci,et al.  Proteinase-Activated Receptor-2 Mediates Arterial Vasodilation in Diabetes , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[20]  T. Hla,et al.  Structural and functional characteristics of S1P receptors , 2004, Journal of cellular biochemistry.

[21]  B. Berk,et al.  Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor β Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells , 2004 .

[22]  G. Cirino,et al.  Upregulation of proteinase‐activated receptors (PARs) and cardiovascular function , 2003 .

[23]  T. Hla,et al.  Sphingosine-1-phosphate signaling in endothelial activation. , 2003, Journal of atherosclerosis and thrombosis.

[24]  T. Michel,et al.  Sphingosine 1-phosphate and control of vascular tone. , 2003, American journal of physiology. Heart and circulatory physiology.

[25]  P. Vallance,et al.  Protease-Activated Receptor 2–Mediated Vasodilatation in Humans In Vivo: Role of Nitric Oxide and Prostanoids , 2003, Circulation.

[26]  B. Berk,et al.  Transactivation of Vascular Endothelial Growth Factor (VEGF) Receptor Flk-1/KDR Is Involved in Sphingosine 1-Phosphate-stimulated Phosphorylation of Akt and Endothelial Nitric-oxide Synthase (eNOS)* , 2002, The Journal of Biological Chemistry.

[27]  A. Lin,et al.  Subcellular Targeting and Agonist-induced Site-specific Phosphorylation of Endothelial Nitric-oxide Synthase* , 2002, The Journal of Biological Chemistry.

[28]  R. A. Kaiser,et al.  Functional Compartmentation of Endothelial P2Y Receptor Signaling , 2002, Circulation research.

[29]  M. Matsuda,et al.  Sphingosine 1-Phosphate Induces Membrane Ruffling and Increases Motility of Human Umbilical Vein Endothelial Cells via Vascular Endothelial Growth Factor Receptor and CrkII* 210 , 2002, The Journal of Biological Chemistry.

[30]  Chen-Yong Lin,et al.  Sphingosine 1-Phosphate, Present in Serum-derived Lipoproteins, Activates Matriptase* , 2002, The Journal of Biological Chemistry.

[31]  T. Palmer,et al.  Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells. , 2001, The Journal of biological chemistry.

[32]  Junsuke Igarashi,et al.  Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase β , 2001, The Journal of Biological Chemistry.

[33]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[34]  J. P. Hobson,et al.  Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility , 2001, Science.

[35]  T. Michel,et al.  Agonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae , 2000, The Journal of Biological Chemistry.

[36]  J. Moffatt,et al.  Protease-activated receptors: sentries for inflammation? , 2000, Trends in pharmacological sciences.

[37]  N. Bunnett,et al.  Trafficking of Proteinase-activated Receptor-2 and β-Arrestin-1 Tagged with Green Fluorescent Protein , 1999, The Journal of Biological Chemistry.

[38]  R. Sorrentino,et al.  Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. , 1999, Circulation.

[39]  C. Sobey,et al.  Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. , 1998, Stroke.

[40]  S. M. Baker,et al.  Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[42]  H. Kanaide,et al.  Role of protease-activated receptors in the vascular system. , 2003, Journal of atherosclerosis and thrombosis.